24
Apr 2026
A new Children's Hospital of Philadelphia study examines the relationship between parenting factors and gaming disorder in young children with attention deficit hyperactivity disorder (ADHD). Findings from the study will be presented during the Pediatric Academic Societies (PAS) 2026 Meeting, taking place April 24-27 in Boston.
23
Apr 2026
In four pre-registered studies across Belgium, the US, and the UK, people judged anti-obesity medication users as putting in less effort and, in turn, viewed them as less moral, competent, warm, and deserving than non-users. The findings suggest that effort moralization may help drive stigma around GLP-1-based weight-loss treatment, even when medication is used alongside diet and exercise.
23
Apr 2026
In a prospective validation study, researchers at The University of Texas MD Anderson Cancer Center demonstrated that a new mathematical model, called LFSPRO, was effective in supporting genetic counselor decision-making and more accurately predicted individuals at higher risk of Li-Fraumeni Syndrome (LFS), a hereditary condition that carries a higher risk of developing multiple cancers.
23
Apr 2026
A study published today in PLOS Medicine has identified two new genetic pathways that contribute to cardiometabolic disease, which includes heart disease, obesity and diabetes.
23
Apr 2026
Memory cells in the nose slow the influenza virus as soon as it enters the body. They reduce viral levels and may help protect against more severe illness.
23
Apr 2026
A major clinical trial has found that real-time continuous glucose monitoring (CGM) significantly improves blood glucose management in adults living with type 2 diabetes who are treated with basal insulin.
23
Apr 2026
People getting their teeth pulled or drilled by dentists in the United States are still much more likely to get powerful opioid medications than dental patients in other developed countries or even the U.S. territory of Puerto Rico, a new study finds.
23
Apr 2026
Thousands of patients sent for vital heart scans may be undergoing unnecessary first-line tests that fail to deliver clear answers - according to new research from the University of East Anglia.
23
Apr 2026
Researchers at City of Hope, a cancer research and treatment organization, and the University of California, Berkeley, have created a novel microfluidic platform that can assess women's breast cancer risk at the cellular level.
23
Apr 2026
One of the biggest challenges in cancer research is understanding why some tumor cells become especially aggressive, invasive and resistant to treatment.
Clinical trials are very important as it allow us to evaluate the effectiveness of new drugs, new devices, preventative strategies or treatment strategies. It also enables us to discover better ways for patients' care.
- Learn more
Our mission remains constant as we endeavor to deliver novel medicines to patients with cancer, treating solid tumors with high unmet medical needs in well-defined patient populations that are currently not well supported.
- Learn more
Whether you're looking to manufacture toxicology batches or cGMP material for clinical trials, we can help you expedite molecules to clinic with full transparency.
- Learn more
